Treatment of Erysipelas
For an otherwise healthy adult without penicillin allergy, treat erysipelas with oral penicillin (500 mg four times daily) or amoxicillin (500 mg three times daily) for 5-10 days. 1
First-Line Antibiotic Selection
The IDSA guidelines clearly establish that therapy for erysipelas should include an antibiotic active against streptococci, as this infection is primarily caused by group A beta-hemolytic streptococcus 1. The evidence strongly supports penicillin-based regimens:
- Penicillin or amoxicillin are the gold standard treatments 1, 2
- These agents specifically target the causative organism (Streptococcus pyogenes) with excellent efficacy
- Studies demonstrate that penicillin achieves faster fever resolution (1.7 days vs 4.5 days with other antibiotics) 3
- A retrospective study of 365 patients found no advantage to using antibiotics other than penicillin, with shorter hospitalization in the penicillin group 4
Treatment Duration
A 5-day course is as effective as 10 days if clinical improvement occurs by day 5 1. This represents an important update from traditional longer courses. However, if improvement is not evident by day 5, continue treatment to complete 10 days.
Oral vs Intravenous Route
Most patients can receive oral therapy from the start 1. Reserve intravenous therapy for patients with:
- Signs of severity (high fever, hypotension, confusion)
- Significant comorbidities (diabetes, arteritis, cirrhosis, immunodeficiency)
- Inability to take oral medications
- Unfavorable social context 2
Alternative Regimens (If Penicillin Allergy)
If the patient has a penicillin allergy, use:
- Clindamycin (first alternative) 1
- Pristinamycin (where available) 2
- Cephalexin (if not severe IgE-mediated allergy) 1
Diagnostic Testing
Do not routinely obtain cultures for typical erysipelas 1. Blood cultures have very low yield (3-7% positive) and rarely change management 4, 3. Reserve blood cultures and tissue sampling for:
- Severe systemic features (high fever, hypotension)
- Immunocompromised patients
- Unusual exposures (animal bites, immersion injuries)
- Malignancy 1
Adjunctive Measures
Beyond antibiotics, implement:
- Leg elevation and bed rest (for lower extremity involvement) 5
- Identify and treat portal of entry (most commonly interdigital tinea/athlete's foot) 5
- Consider anticoagulation in patients at risk for venous thromboembolism 5
Common Pitfalls to Avoid
Do not use broad-spectrum antibiotics unnecessarily. A retrospective study found that two-thirds of hospitalized patients received very broad-spectrum treatment, but failure rates were identical (12%) regardless of spectrum 1. This represents overtreatment and increases costs and adverse effects without benefit.
Do not confuse erysipelas with purulent collections. The distinction is critical: erysipelas requires antibiotics as primary treatment, while abscesses require drainage with antibiotics playing a subsidiary role 1.
Recognize that constitutional symptoms (fever, chills) occurring at or before erythema onset strongly suggest erysipelas (present in 91.4% of cases) versus cellulitis (36.2%), supporting the diagnosis and penicillin selection 6.
Recurrence Prevention
For patients with recurrent erysipelas (the most common complication):